Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications

Paola Brusa, Francesca Baratta, Massimo Collino, Shimon Ben -Shabat

Research output: Contribution to journalEditorial

3 Scopus citations

Abstract

Cannabis has been used in even the oldest traditional medicines available. In the last century, negative attention has prevailed regarding the psychotropic and abuse potential. For this reason, Cannabis has been banned and declared illegal in many countries. In recent years, however, there has been a more in-depth evaluation of the legalization of cannabinoids for medical use in several countries following heightened media attention and reports of effectiveness, although not always thoroughly backed up by scientific evidence. The official introduction of pharmaceutical-grade Cannabis inflorescences for medicinal purposes has allowed physicians and pharmacists, to prescribe and prepare several Cannabis preparations legally. Such products are currently being administered to patients without their efficacy being evaluated in controlled studies: for each patient the composition and route of administration may differ. In addition, many advanced administration systems have been developed or are still under development, but few clinical trials have been completed.
In this context, this Research Topic focused on the in-depth analysis of the legal, technological and pharmacological aspects related to the medical use of Cannabis-based formulations.
Original languageEnglish
Article number999068
JournalFrontiers in Pharmacology
Volume13
DOIs
StatePublished - 25 Aug 2022

Keywords

  • Cannabis
  • clinical trials
  • effectiveness
  • formulations
  • medical use

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications'. Together they form a unique fingerprint.

Cite this